» Articles » PMID: 25981709

Peripheral Conduit and Resistance Artery Function Are Improved Following a Single, 1-h Bout of Peristaltic Pulse External Pneumatic Compression

Overview
Specialty Physiology
Date 2015 May 19
PMID 25981709
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: External pneumatic compression (EPC) is being employed for a widening range of clinical and non-clinical populations. However, EPC devices vary markedly in treatment pressures, duty cycles and application sites, and the acute effects of whole limb, lower pressure EPC on peripheral vascular function have not been determined.

Purpose: The purpose of this study was to determine the acute effects of a single bout of peristaltic pulse EPC on peripheral conduit and resistance artery function.

Methods: Twenty (n = 20; males = 12 and females = 8) young and apparently healthy subjects (aged 26.1 ± 8.2 years) participated in this study. A sequential EPC device with five inflation zones arranged linearly and inflating distal to proximal along the lower limbs was employed with target inflation pressures of 70 mmHg for 1 h. Flow-mediated dilation (FMD) of the brachial and popliteal arteries was evaluated with ultrasound before and after EPC. Venous occlusion plethysmography was employed to evaluate limb blood flow at rest and during reactive hyperemia (RH) in the forearm (FBF) and calf (CBF) before and after EPC.

Results: Peak RH CBF was increased by 9 % after EPC (P < 0.05), whereas peak RH FBF (-10 %) did not change significantly (P > 0.25). Normalized popliteal artery FMD post-EPC (2.24 ± 1.41) was significantly higher than pre-EPC (1.36 ± 0.67, P = 0.015) and post-sham (1.58 ± 0.86, P = 0.032) values. Similarly, normalized brachial artery FMD post-EPC (1.47 ± 0.32) was significantly higher than pre-EPC (1.11 ± 0.41, P = 0.004) and post-sham (0.99 ± 0.27, P = 0.026) values.

Conclusion: Acutely, whole limb, lower pressure EPC improves conduit artery endothelial function systemically, but only improves RH blood flow locally (i.e., compressed limbs).

Citing Articles

The Healthspan Project: A Retrospective Pilot of Biomarkers and Biometric Outcomes after a 6-Month Multi-Modal Wellness Intervention.

Chun E, Crete A, Neal C, Joseph R, Pojednic R Healthcare (Basel). 2024; 12(6).

PMID: 38540640 PMC: 10970491. DOI: 10.3390/healthcare12060676.


Effects of intermittent pneumatic compression on the recovery of cardiovascular parameters after repeated sprint exercise.

Artes A, Ferrer-Ramos P, Javierre C, Viscor G, Garcia I Eur J Appl Physiol. 2023; 124(4):1037-1048.

PMID: 37792163 PMC: 10954933. DOI: 10.1007/s00421-023-05333-x.


Effects of different intermittent pneumatic compression stimuli on ankle dorsiflexion range of motion.

Yanaoka T, Numata U, Nagano K, Kurosaka S, Kawashima H Front Physiol. 2022; 13:1054806.

PMID: 36505057 PMC: 9726923. DOI: 10.3389/fphys.2022.1054806.


Effects of an external pneumatic compression device vs static compression garment on peripheral circulation and markers of sports performance and recovery.

Blumkaitis J, Moon J, Ratliff K, Stecker R, Richmond S, Sunderland K Eur J Appl Physiol. 2022; 122(7):1709-1722.

PMID: 35475921 DOI: 10.1007/s00421-022-04953-z.


Effects of Intermittent Pneumatic Compression on Delayed Onset Muscle Soreness (DOMS) in Long Distance Runners.

Draper S, Kullman E, Sparks K, Little K, Thoman J Int J Exerc Sci. 2020; 13(2):75-86.

PMID: 32148616 PMC: 7039487. DOI: 10.70252/HSPN3402.


References
1.
Clifford P, Kluess H, Hamann J, Buckwalter J, Jasperse J . Mechanical compression elicits vasodilatation in rat skeletal muscle feed arteries. J Physiol. 2006; 572(Pt 2):561-7. PMC: 1779686. DOI: 10.1113/jphysiol.2005.099507. View

2.
Gurovich A, Braith R . Enhanced external counterpulsation creates acute blood flow patterns responsible for improved flow-mediated dilation in humans. Hypertens Res. 2012; 36(4):297-305. DOI: 10.1038/hr.2012.169. View

3.
Martin J, Braith R . Anti-inflammatory effects of enhanced external counterpulsation in subjects with abnormal glucose tolerance. Appl Physiol Nutr Metab. 2012; 37(6):1251-5. DOI: 10.1139/h2012-112. View

4.
Wilkinson I, Webb D . Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol. 2001; 52(6):631-46. PMC: 2014568. DOI: 10.1046/j.0306-5251.2001.01495.x. View

5.
Horman S, Morel N, Vertommen D, Hussain N, Neumann D, Beauloye C . AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase. J Biol Chem. 2008; 283(27):18505-12. DOI: 10.1074/jbc.M802053200. View